Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitigating Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery
NCT06864312Phase 4Completed
- Sponsor
- University College Cork
- Start
- Oct 2023
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levobupivacaine and oxycodone (3 arms), sponsored by University College Cork. Primary endpoint: Median peak pain score at 24 hours. Started Oct 2023; status: completed.
02
Drugs
levobupivacaineoxycodone
Beyond the preview
Go deeper on NCT06864312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06864312.